Alain Turcant
Papers
2
Total Citations
24
H-Index
2
About
Alain Turcant is a pioneering figure in clinical toxicology and analytical chemistry, best known for advancing automated flow-injection analysis (FIA) techniques to streamline drug monitoring and enzyme diagnostics. His work bridges the gap between high-performance liquid chromatography (HPLC) instrumentation and rapid, reliable clinical assays. In his most cited study (15 citations), Turcant developed an automated fluoroimmunoassay for theophylline and valproic acid, integrating a robotic sample processor with a fluorometer to achieve precise, high-throughput therapeutic drug monitoring—a method that reduced manual error and turnaround time in hospital labs. His second key contribution (9 citations) introduced an automated spectrophotometric method for measuring cholinesterase activity in plasma and erythrocytes, enabling the identification of individuals sensitive to succinylcholine, a critical safety tool in anesthesia. By repurposing HPLC components for FIA, Turcant demonstrated how existing lab infrastructure could be adapted for novel, cost-effective diagnostics. His work remains foundational for researchers developing automated, low-volume assays in clinical pharmacology and toxicology, showcasing the power of cross-disciplinary engineering to solve real-world medical challenges.
Research Focus
Key Achievements
Top Papers
- 1
- 2